Nemaura Medical Inc. (NMRD)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -9.59 Million USD | -26.75% |
| 2022 | -7.57 Million USD | -65.05% |
| 2021 | -4.58 Million USD | 4.01% |
| 2020 | -4.77 Million USD | -6.74% |
| 2019 | -4.47 Million USD | -134.51% |
| 2018 | -1.9 Million USD | -23.06% |
| 2017 | -1.55 Million USD | -0.76% |
| 2016 | -1.53 Million USD | -16.65% |
| 2015 | -1.31 Million USD | -125.14% |
| 2014 | -586.23 Thousand USD | 29.42% |
| 2013 | -830.57 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -1.83 Million USD | 57.21% |
| 2024 Q3 | -1.54 Million USD | 24.84% |
| 2024 Q2 | -2.05 Million USD | -11.8% |
| 2023 Q2 | -1.62 Million USD | 26.52% |
| 2023 FY | -9.59 Million USD | -26.75% |
| 2023 Q4 | -4.28 Million USD | -576.87% |
| 2023 Q3 | -633.32 Thousand USD | 61.02% |
| 2023 Q1 | -2.21 Million USD | 9.48% |
| 2022 Q4 | -2.44 Million USD | -36.28% |
| 2022 Q1 | -1.62 Million USD | -17.49% |
| 2022 Q2 | -1.71 Million USD | -5.81% |
| 2022 Q3 | -1.79 Million USD | -4.52% |
| 2022 FY | -7.57 Million USD | -65.05% |
| 2021 Q3 | -1.06 Million USD | 12.98% |
| 2021 FY | -4.58 Million USD | 4.01% |
| 2021 Q4 | -1.37 Million USD | -29.1% |
| 2021 Q1 | -911.03 Thousand USD | 32.36% |
| 2021 Q2 | -1.22 Million USD | -34.77% |
| 2020 Q2 | -1.11 Million USD | 11.01% |
| 2020 Q1 | -1.25 Million USD | 22.73% |
| 2020 FY | -4.77 Million USD | -6.74% |
| 2020 Q4 | -1.34 Million USD | -27.14% |
| 2020 Q3 | -1.05 Million USD | 5.16% |
| 2019 Q1 | -771.96 Thousand USD | -35.96% |
| 2019 FY | -4.47 Million USD | -134.51% |
| 2019 Q4 | -1.62 Million USD | -74.13% |
| 2019 Q3 | -932.92 Thousand USD | 18.69% |
| 2019 Q2 | -1.14 Million USD | -48.63% |
| 2018 Q4 | -567.77 Thousand USD | -19.19% |
| 2018 Q3 | -476.35 Thousand USD | -6.44% |
| 2018 Q2 | -447.51 Thousand USD | -7.24% |
| 2018 Q1 | -417.32 Thousand USD | -16.17% |
| 2018 FY | -1.9 Million USD | -23.06% |
| 2017 FY | -1.55 Million USD | -0.76% |
| 2017 Q4 | -359.23 Thousand USD | 4.3% |
| 2017 Q3 | -375.36 Thousand USD | -16.4% |
| 2017 Q2 | -322.48 Thousand USD | 34.74% |
| 2017 Q1 | -494.18 Thousand USD | -18.31% |
| 2016 Q1 | -402.82 Thousand USD | 24.84% |
| 2016 FY | -1.53 Million USD | -16.65% |
| 2016 Q4 | -417.71 Thousand USD | -27.05% |
| 2016 Q3 | -328.78 Thousand USD | 15.76% |
| 2016 Q2 | -390.3 Thousand USD | 3.11% |
| 2015 Q4 | -535.93 Thousand USD | -237.57% |
| 2015 FY | -1.31 Million USD | -125.14% |
| 2015 Q1 | -269.25 Thousand USD | -66.07% |
| 2015 Q2 | -355.88 Thousand USD | -32.18% |
| 2015 Q3 | -158.76 Thousand USD | 55.39% |
| 2014 Q1 | -61.77 Thousand USD | 70.25% |
| 2014 Q3 | -340.19 Thousand USD | -1437.12% |
| 2014 Q4 | -162.12 Thousand USD | 52.34% |
| 2014 FY | -586.23 Thousand USD | 29.42% |
| 2014 Q2 | -22.13 Thousand USD | 64.17% |
| 2013 Q4 | -207.64 Thousand USD | 0.0% |
| 2013 FY | -830.57 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 33.185% |
| Cerus Corporation | -30.05 Million USD | 68.072% |
| OrthoPediatrics Corp. | -25.76 Million USD | 62.76% |
| PetVivo Holdings, Inc. | -10.62 Million USD | 9.661% |
| Talis Biomedical Corporation | -66.81 Million USD | 85.639% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 44.523% |
| Inogen, Inc. | -109.38 Million USD | 91.228% |
| Spectral AI, Inc. | -12.98 Million USD | 26.1% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 84.669% |
| CVRx, Inc. | -43.1 Million USD | 77.739% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -171.974% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | 22.793% |
| Orthofix Medical Inc. | -139.11 Million USD | 93.102% |
| Venus Concept Inc. | -28.3 Million USD | 66.105% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 82.24% |
| Bioventus Inc. | -81.72 Million USD | 88.259% |
| BrainsWay Ltd. | -4.92 Million USD | -94.748% |
| Envoy Medical, Inc. | -18.37 Million USD | 47.77% |
| electroCore, Inc. | -18.8 Million USD | 48.975% |
| IceCure Medical Ltd | -15.57 Million USD | 38.397% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 80.209% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 44.434% |
| MaxCyte, Inc. | -48.29 Million USD | 80.134% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | 19.74% |
| Nexalin Technology, Inc. | -5.69 Million USD | -68.447% |
| PAVmed Inc | -68.79 Million USD | 86.052% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 83.036% |
| RxSight, Inc. | -50.08 Million USD | 80.842% |
| Sight Sciences, Inc. | -57.27 Million USD | 83.247% |
| SI-BONE, Inc. | -46.93 Million USD | 79.555% |
| TELA Bio, Inc. | -44.07 Million USD | 78.23% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 82.28% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 81.342% |
| LivaNova PLC | -68.49 Million USD | 85.992% |
| 908 Devices Inc. | -42.75 Million USD | 77.559% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 94.466% |
| NeuroPace, Inc. | -27.17 Million USD | 64.69% |
| LENSAR, Inc. | -12.22 Million USD | 21.537% |
| Apyx Medical Corporation | -17.25 Million USD | 44.404% |
| Cutera, Inc. | -156.23 Million USD | 93.858% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -11.521% |
| BioSig Technologies, Inc. | -28.51 Million USD | 66.347% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 89.051% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 57.252% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 108.604% |
| Axonics, Inc. | -26.05 Million USD | 63.176% |
| Outset Medical, Inc. | -169.77 Million USD | 94.348% |
| IRIDEX Corporation | -10 Million USD | 4.115% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 91.211% |
| IRadimed Corporation | 20.03 Million USD | 147.891% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -16.376% |
| INVO Bioscience, Inc. | -6.76 Million USD | -41.791% |
| Telesis Bio, Inc. | -35.15 Million USD | 72.702% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 166.959% |
| Varex Imaging Corporation | 32.1 Million USD | 129.892% |
| Quipt Home Medical Corp. | 3.91 Million USD | 344.839% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 20.916% |
| Pulmonx Corporation | -61.93 Million USD | 84.508% |
| Dynatronics Corporation | -2.27 Million USD | -322.131% |
| Modular Medical, Inc. | -17.52 Million USD | 45.261% |
| ReShape Lifesciences Inc. | -14.63 Million USD | 34.454% |
| Semler Scientific, Inc. | 22.25 Million USD | 143.113% |
| InMode Ltd. | 195.66 Million USD | 104.904% |
| Bruker Corporation | 436.9 Million USD | 102.196% |
| Cytosorbents Corporation | -31.2 Million USD | 69.255% |
| DexCom, Inc. | 597.7 Million USD | 101.605% |
| Align Technology, Inc. | 643.33 Million USD | 101.491% |
| Viveve Medical, Inc. | -21.55 Million USD | 55.481% |
| ZimVie Inc. | -30.93 Million USD | 68.987% |
| Movano Inc. | -29.69 Million USD | 67.682% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 65.541% |
| Nexalin Technology, Inc. | -5.69 Million USD | -68.447% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -171.974% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 95.886% |
| Profound Medical Corp. | -28.61 Million USD | 66.469% |
| Insulet Corporation | 220 Million USD | 104.361% |
| enVVeno Medical Corporation | -25.23 Million USD | 61.981% |
| Surmodics, Inc. | -5.64 Million USD | -69.978% |
| iCAD, Inc. | -7.68 Million USD | -24.792% |
| Nuwellis, Inc. | -17.63 Million USD | 45.574% |
| Biotricity, Inc. | -8.82 Million USD | -8.688% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 92.334% |
| Aethlon Medical, Inc. | -12.63 Million USD | 24.068% |
| InspireMD, Inc. | -21.14 Million USD | 54.617% |
| PAVmed Inc. | -68.79 Million USD | 86.052% |
| BIOLASE, Inc. | -17.93 Million USD | 46.506% |
| Beyond Air, Inc. | -63 Million USD | 84.771% |
| FONAR Corporation | 16.53 Million USD | 158.029% |
| AxoGen, Inc. | -21.46 Million USD | 55.292% |
| Vivani Medical, Inc. | -26.96 Million USD | 64.416% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 153.186% |
| Inari Medical, Inc. | -14.03 Million USD | 31.619% |
| UFP Technologies, Inc. | 57.66 Million USD | 116.64% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -94.724% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -52.166% |
| Tenon Medical, Inc. | -15.72 Million USD | 38.989% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -28.382% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 77.532% |
| AdaptHealth Corp. | -598.4 Million USD | 98.397% |
| Sintx Technologies, Inc. | -13.35 Million USD | 28.169% |
| NanoVibronix, Inc. | -3.43 Million USD | -179.256% |
| Quanterix Corporation | -49.7 Million USD | 80.694% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 20.916% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -2411.841% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 97.131% |
| TransMedics Group, Inc. | -28.72 Million USD | 66.599% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 59.363% |
| NeuroMetrix, Inc. | -7.15 Million USD | -34.171% |
| Hyperfine, Inc. | -48.11 Million USD | 80.058% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 85.244% |
| Biomerica, Inc. | -6.36 Million USD | -50.703% |
| Bone Biologics Corporation | -9.42 Million USD | -1.771% |
| AVITA Medical, Inc. | -40.4 Million USD | 76.251% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | 6.944% |
| Silk Road Medical, Inc | -59.27 Million USD | 83.811% |